<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Presseportal.de - Merck and Co., Inc.</title>
    <link>http://www.presseportal.de/pm/8150/merck_and_co_inc/</link>
    <description>Presseportal.de: Merck and Co., Inc. (Digitale Pressemappe)</description>
    <language>de-de</language>
    <copyright>news aktuell GmbH</copyright>
    <managingEditor>redaktion@presseportal.de</managingEditor>
    <pubDate>Sat, 20 Mar 2010 00:00:01 +0100</pubDate>
    <lastBuildDate>Tue, 02 Sep 2008 19:30:00 +0200</lastBuildDate>
    <category></category>
    <ttl>6</ttl>
    <image>
      <url>http://www.presseportal.de/images/logo_napresseportal.gif</url>
      <title>Presseportal.de</title>
      <link>http://www.presseportal.de/pm/8150/merck_and_co_inc/</link>
    </image>
                                                          <item>
        <title>New Survey Among European Cardiologists Points to a Gap in Cardiovascular Disease Management</title>
        <guid>http://www.presseportal.de/pm/8150/1257885/merck_and_co_inc/rss</guid>
        <description>Merck and Co., Inc.: Munich, Germany (ots/PRNewswire) - - In spite of the success of therapies targeting LDL in lowering cardiovascular risk, a residual risk still remains Cardiologists in Europe agree that reducing LDL-cholesterol (LDL-C or &quot;bad&quot; ...</description>
        <content:encoded><![CDATA[<b>Merck and Co., Inc.</b> [<a href="http://www.presseportal.de/pm/8150/merck_and_co_inc/rss">Pressemappe</a>]<br>
                            Munich, Germany (ots/PRNewswire) - - In spite of the success of therapies targeting LDL in lowering cardiovascular risk, a residual risk still remains Cardiologists in Europe agree that reducing LDL-cholesterol (LDL-C or &quot;bad&quot; ...
            <a href="http://www.presseportal.de/pm/8150/1257885/merck_and_co_inc/rss">Lesen Sie hier weiter...</a>
        <br clear="all" /><IMG SRC="http://presspor.ivwbox.de/cgi-bin/ivw/CP/de_1003" WIDTH="1" HEIGHT="1">]]></content:encoded>
        <link>http://www.presseportal.de/pm/8150/1257885/merck_and_co_inc/rss</link>
        <category>Wirtschaft</category>
        <pubDate>Tue, 02 Sep 2008 19:30:00 +0200</pubDate>
        <author>redaktion@presseportal.de</author>
        <source url="http://www.presseportal.de/pm/8150/1257885/merck_and_co_inc/rss">Merck and Co., Inc.</source>
        </item>
                                                          <item>
        <title>Merck&apos;s earnings per share increased 18% for 2000 driven by the strong momentum of five key products</title>
        <guid>http://www.presseportal.de/pm/8150/213617/merck_and_co_inc/rss</guid>
        <description>Merck and Co., Inc.:    Whitehouse Station, New Jersey (ots-PRNewswire) - Merck &amp; Co.,
Inc. (NYSE: MRK) today announced that earnings per share for 2000
were $2.90, an increase of 18% over 1999.  Net income grew 16% to
$6,821.7 million, fuelled by a 23% sales increase ...</description>
        <content:encoded><![CDATA[<b>Merck and Co., Inc.</b> [<a href="http://www.presseportal.de/pm/8150/merck_and_co_inc/rss">Pressemappe</a>]<br>
                               Whitehouse Station, New Jersey (ots-PRNewswire) - Merck &amp; Co.,
Inc. (NYSE: MRK) today announced that earnings per share for 2000
were $2.90, an increase of 18% over 1999.  Net income grew 16% to
$6,821.7 million, fuelled by a 23% sales increase ...
            <a href="http://www.presseportal.de/pm/8150/213617/merck_and_co_inc/rss">Lesen Sie hier weiter...</a>
        <br clear="all" /><IMG SRC="http://presspor.ivwbox.de/cgi-bin/ivw/CP/de_1003" WIDTH="1" HEIGHT="1">]]></content:encoded>
        <link>http://www.presseportal.de/pm/8150/213617/merck_and_co_inc/rss</link>
        <category>Wirtschaft</category>
        <pubDate>Tue, 23 Jan 2001 15:11:00 +0200</pubDate>
        <author>redaktion@presseportal.de</author>
        <source url="http://www.presseportal.de/pm/8150/213617/merck_and_co_inc/rss">Merck and Co., Inc.</source>
        </item>
                                                          <item>
        <title>Merck Cites Strong Growth In Presentation To Analysts / Momentum of Key Products Fuels Confidence in Company&apos;s Future</title>
        <guid>http://www.presseportal.de/pm/8150/202685/merck_and_co_inc/rss</guid>
        <description>Merck and Co., Inc.:    Whitehouse Station, N.J. (ots-PRNewswire) - Merck has created a
strong platform for growth and is delivering outstanding performance,
Merck Chairman, President and CEO Raymond V. Gilmartin told more than
300 securities analysts today at the ...</description>
        <content:encoded><![CDATA[<b>Merck and Co., Inc.</b> [<a href="http://www.presseportal.de/pm/8150/merck_and_co_inc/rss">Pressemappe</a>]<br>
                               Whitehouse Station, N.J. (ots-PRNewswire) - Merck has created a
strong platform for growth and is delivering outstanding performance,
Merck Chairman, President and CEO Raymond V. Gilmartin told more than
300 securities analysts today at the ...
            <a href="http://www.presseportal.de/pm/8150/202685/merck_and_co_inc/rss">Lesen Sie hier weiter...</a>
        <br clear="all" /><IMG SRC="http://presspor.ivwbox.de/cgi-bin/ivw/CP/de_1003" WIDTH="1" HEIGHT="1">]]></content:encoded>
        <link>http://www.presseportal.de/pm/8150/202685/merck_and_co_inc/rss</link>
        <category>Wirtschaft</category>
        <pubDate>Tue, 12 Dec 2000 17:15:00 +0200</pubDate>
        <author>redaktion@presseportal.de</author>
        <source url="http://www.presseportal.de/pm/8150/202685/merck_and_co_inc/rss">Merck and Co., Inc.</source>
        </item>
                                                          <item>
        <title>Merck &amp; Co., Inc. and probiodrug GmbH Sign Exclusive Worldwide Licensing Arrangement</title>
        <guid>http://www.presseportal.de/pm/8150/202261/merck_and_co_inc/rss</guid>
        <description>Merck and Co., Inc.:    Whitehouse Station, N.J. (ots-PRNewswire) - Merck &amp; Co., Inc. 
(NYSE: MRK) and probiodrug Gesellschaft fur Arzneimittelforschung
mbH, Halle/Saale, Germany announced today that they have signed a
licensing  agreement that gives Merck certain ...</description>
        <content:encoded><![CDATA[<b>Merck and Co., Inc.</b> [<a href="http://www.presseportal.de/pm/8150/merck_and_co_inc/rss">Pressemappe</a>]<br>
                               Whitehouse Station, N.J. (ots-PRNewswire) - Merck &amp; Co., Inc. 
(NYSE: MRK) and probiodrug Gesellschaft fur Arzneimittelforschung
mbH, Halle/Saale, Germany announced today that they have signed a
licensing  agreement that gives Merck certain ...
            <a href="http://www.presseportal.de/pm/8150/202261/merck_and_co_inc/rss">Lesen Sie hier weiter...</a>
        <br clear="all" /><IMG SRC="http://presspor.ivwbox.de/cgi-bin/ivw/CP/de_1003" WIDTH="1" HEIGHT="1">]]></content:encoded>
        <link>http://www.presseportal.de/pm/8150/202261/merck_and_co_inc/rss</link>
        <category>Vermischtes</category>
        <pubDate>Mon, 11 Dec 2000 16:19:00 +0200</pubDate>
        <author>redaktion@presseportal.de</author>
        <source url="http://www.presseportal.de/pm/8150/202261/merck_and_co_inc/rss">Merck and Co., Inc.</source>
        </item>
                                                          <item>
        <title>Merck&apos;s Earnings Per Share Increased 22% for the Third Quarter 2000, Driven By Record Sales of More Than $10 Billion</title>
        <guid>http://www.presseportal.de/pm/8150/185408/merck_and_co_inc/rss</guid>
        <description>Merck and Co., Inc.:    Whitehouse station, N.J. (ots-PRNewswire) - Merck &amp; Co., Inc.
(NYSE: MRK) today announced that earnings per share for the third
quarter of 2000 were $0.78, up 22% over the third quarter of 1999.
For the quarter, net income increased 19% to ...</description>
        <content:encoded><![CDATA[<b>Merck and Co., Inc.</b> [<a href="http://www.presseportal.de/pm/8150/merck_and_co_inc/rss">Pressemappe</a>]<br>
                               Whitehouse station, N.J. (ots-PRNewswire) - Merck &amp; Co., Inc.
(NYSE: MRK) today announced that earnings per share for the third
quarter of 2000 were $0.78, up 22% over the third quarter of 1999.
For the quarter, net income increased 19% to ...
            <a href="http://www.presseportal.de/pm/8150/185408/merck_and_co_inc/rss">Lesen Sie hier weiter...</a>
        <br clear="all" /><IMG SRC="http://presspor.ivwbox.de/cgi-bin/ivw/CP/de_1003" WIDTH="1" HEIGHT="1">]]></content:encoded>
        <link>http://www.presseportal.de/pm/8150/185408/merck_and_co_inc/rss</link>
        <category>Vermischtes</category>
        <pubDate>Fri, 20 Oct 2000 14:22:00 +0200</pubDate>
        <author>redaktion@presseportal.de</author>
        <source url="http://www.presseportal.de/pm/8150/185408/merck_and_co_inc/rss">Merck and Co., Inc.</source>
        </item>
                                                          <item>
        <title>Merck kündigt Impfstoffspende im Wert von $100 Millionen an und bestätigt das Firmenengagement in der Impfstofforschung bei einem Treffen im Weißen Haus erneut</title>
        <guid>http://www.presseportal.de/pm/8150/117895/merck_and_co_inc/rss</guid>
        <description>Merck and Co., Inc.:    Whitehouse Station, New Jersey (ots-PRNewswire) - Merck &amp; Co. Inc.
(NYSE: MRK) unterstützt die verstärkten internationalen Bemühungen
zur Verbesserung der weltweiten gesundheitlichen und wirtschaftlichen
Entwicklung durch Krankheitsvorbeugung und ...</description>
        <content:encoded><![CDATA[<b>Merck and Co., Inc.</b> [<a href="http://www.presseportal.de/pm/8150/merck_and_co_inc/rss">Pressemappe</a>]<br>
                               Whitehouse Station, New Jersey (ots-PRNewswire) - Merck &amp; Co. Inc.
(NYSE: MRK) unterstützt die verstärkten internationalen Bemühungen
zur Verbesserung der weltweiten gesundheitlichen und wirtschaftlichen
Entwicklung durch Krankheitsvorbeugung und ...
            <a href="http://www.presseportal.de/pm/8150/117895/merck_and_co_inc/rss">Lesen Sie hier weiter...</a>
        <br clear="all" /><IMG SRC="http://presspor.ivwbox.de/cgi-bin/ivw/CP/de_1003" WIDTH="1" HEIGHT="1">]]></content:encoded>
        <link>http://www.presseportal.de/pm/8150/117895/merck_and_co_inc/rss</link>
        <category>Wirtschaft</category>
        <pubDate>Thu, 02 Mar 2000 22:39:00 +0200</pubDate>
        <author>redaktion@presseportal.de</author>
        <source url="http://www.presseportal.de/pm/8150/117895/merck_and_co_inc/rss">Merck and Co., Inc.</source>
        </item>
      </channel>
</rss>